Entity Common Stock, Shares Outstanding of ZEVRA THERAPEUTICS, INC. from 28 May 2015 to 06 Mar 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ZEVRA THERAPEUTICS, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 28 May 2015 to 06 Mar 2026.
  • ZEVRA THERAPEUTICS, INC. Entity Common Stock, Shares Outstanding for the quarter ending 06 Mar 2026 was 58,711,584, a 8.5% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

ZEVRA THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 58,711,584 +4,595,715 +8.5% 06 Mar 2026 10-K 09 Mar 2026 2025 FY
Q3 2025 56,297,535 +2,921,603 +5.5% 03 Nov 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 56,135,091 +3,517,302 +6.7% 08 Aug 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 54,115,869 +10,689,683 +25% 07 Mar 2025 10-K 12 Mar 2025 2024 FY
Q3 2024 53,375,932 +17,157,768 +47% 13 Nov 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 52,617,789 +18,685,150 +55% 12 Aug 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 43,426,186 +8,885,772 +26% 30 Mar 2024 10-K 01 Apr 2024 2023 FY
Q3 2023 36,218,164 +1,713,302 +5% 03 Nov 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 33,932,639 -560,995 -1.6% 11 Aug 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 34,540,414 +117,911 +0.34% 03 Mar 2023 10-K 07 Mar 2023 2022 FY
Q3 2022 34,504,862 -814,564 -2.3% 08 Nov 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 34,493,634 -660,115 -1.9% 11 Aug 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 34,422,503 +6,046,182 +21% 29 Mar 2022 10-K 31 Mar 2022 2021 FY
Q3 2021 35,319,426 -37,225,411 -51% 09 Nov 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 35,153,749 -37,310,092 -51% 12 Aug 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 28,376,321 -22,308,422 -44% 10 Mar 2021 10-K 12 Mar 2021 2020 FY
Q3 2020 72,544,837 +39,320,960 +118% 28 Oct 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 72,463,841 +42,705,298 +144% 11 Aug 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 50,684,743 +24,229,391 +92% 26 Feb 2020 10-K 28 Feb 2020 2019 FY
Q3 2019 33,223,877 +6,768,525 +26% 14 Nov 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 29,758,543 +13,716,525 +86% 12 Aug 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 26,455,352 +11,350,504 +75% 28 Feb 2019 10-K 01 Mar 2019 2018 FY
Q3 2018 26,455,352 +11,797,922 +80% 08 Nov 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 16,042,018 +1,384,588 +9.4% 09 Aug 2018 10-Q 10 Aug 2018 2018 Q2
Q1 2018 15,104,848 +457,866 +3.1% 28 Mar 2018 10-K 30 Mar 2018 2017 FY
Q3 2017 14,657,430 +10,448 +0.07% 08 Nov 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 14,657,430 +10,448 +0.07% 09 Aug 2017 10-Q 10 Aug 2017 2017 Q2
Q1 2017 14,646,982 +148,508 +1% 07 Mar 2017 10-K 10 Mar 2017 2016 FY
Q3 2016 14,646,982 +198,156 +1.4% 08 Nov 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 14,646,982 +420,671 +3% 09 Aug 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 14,498,474 11 Mar 2016 10-K 16 Mar 2016 2015 FY
Q3 2015 14,448,826 11 Nov 2015 10-Q 13 Nov 2015 2015 Q3
Q2 2015 14,226,311 28 May 2015 10-Q 29 May 2015 2015 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.